Cancer Archives

header asper biotech biotech of the week

News and Trends 3 Jun 2016

Biotech of the Week: High-quality genetic testing with Asper Biotech in Estonia

This week we decided we needed a geographical change and explore slightly different territories… The Baltic sea was a good solution, we thought, so that’s why we are leaving Paris to head up to Tartu, in Estonia, to visit Asper Biotech, our Biotech of the Week. City: Tartu (Estonia) Founded: 1999 Employees: 11 – 50 (as of […]

June 3, 2016 - 2 minutesmins - By Joachim Eeckhout

MiNa therapeutics rna liver disease biotech

News and Trends 2 Jun 2016

RNA therapy starts first-of-a-kind trial to treat Liver Cancer

MiNA Therapeutics is launching the first saRNA human trial of its kind – OUTREACH for patients with severe liver cancer. MiNA Therapeutics is a London based RNA specialist, developing RNA activation therapeutics that restore normal function to patients’ cells with an initial focus on severe liver cancer. The study is the first-in-human trial of a small activating RNA […]

June 2, 2016 - 2 minutesmins - By Dani Bancroft

biontech mrna vaccine cancer immunotherapy nature

News and Trends 2 Jun 2016

First All-Cancer mRNA Vaccine that Works Published in Nature

Update (05/07/2017): BioNTech has published new results in Nature revealing a strong immune response in all 13 patients treated with its personalized mRNA cancer vaccine, strengthening its potential to become a universal cancer vaccine. Originally published on 02/06/2016 BioNTech and its academic partners have published in the well-known publication Nature, describing the first clinically applicable and systemic […]

June 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

nasdaq merus biotech ipo closing immunooncology cancer breast ovarian colorectal finance

News and Trends 30 May 2016

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

The Utrecht based Merus has snagged around $47.3M (€42.5M) in an IPO on the NASDAQ market for its portfolio of antibodies targeting breast and colorectal cancers. Back in April 2015, Merus announced its intention to go public on the Nasdaq, with the goal of raising at least €100M for the rest of the year, but […]

May 30, 2016 - 2 minutesmins - By Dani Bancroft

blood cancer disease model, multi-omics, CAR-T, oncology

News and Trends 28 May 2016

It’s Blood Cancer Day, how is Biotech fixing it?

Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers – which are still often deadly. Blood cancers can affect different type of cells in the blood. Because these cells are so close to the circulatory and immune system, […]

May 28, 2016 - 4 minutesmins - By Denise Neves Gameiro

qiagen therawis diagnostics chemotherapy tnbc

News and Trends 26 May 2016

Qiagen partners up for Novel Diagnostic against Breast Cancer

Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be in patients with high risk breast cancer. A giant in molecular diagnostics, Qiagen is now working in a new diagnostic test that could help guide the treatment of breast cancer. Now, Qiagen has partnered with […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

biotech immunicum cancer immunotherapy biotechnology europe

News and Trends 20 May 2016

Biotech of the Week: Immunicum, Immuno-oncology made in Sweden

We like Scandinavia so much we just don’t want to leave, therefore, we’re heading back East again! This time, Gothenburg is our destination. Being the second biggest city in Sweden and having the biggest harbor in the Northern countries (and once the hosting city for the Eurovision Song Contest in 1985) it is also where […]

May 20, 2016 - 2 minutesmins - By Joachim Eeckhout

roche fda pd l1 checkpoint inhibitor atezolizumab

News and Trends 19 May 2016

FDA approves First ever antibody to target Cancer PD-L1

Roche has received market approval for atezolizumab to treat a common type of bladder cancer. It’s the 3rd checkpoint inhibitor on the market, and the first to target PD-L1. Immuno-oncology is a hype field that promises to revolutionize cancer treatment, with a lot of active research and big deals (like the €600M deal between argenx […]

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

imab ganymed gastroesophegal cancer asco

News and Trends 17 May 2016

‘Ideal’ German Antibodies have promising data for Gastro Cancer

Ganymed is presenting promising results of its phase II trial in gastroesophageal cancer at the ASCO Annual meeting 2016 in Chicago, one of the leading Oncology conferences worldwide. Based in Mainz (Germany), Ganymed is a Biopharma developing immunotherapies to tackle cancer, having joined forces with BioNTech (Germany’s larget private Biotech) 2 years ago to create […]

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

abbvie bms empliciti multiple myeloma cancer immunooncology ema

News and Trends 13 May 2016

First and only antibody for Multiple Myeloma approved in EU

Bristol-Myers Squibb and AbbVie have announced that their co-development project for an antibody therapy against Multiple Myeloma has been approved in the EU after a successful Phase III trial. Empliciti (elotuzumab) has been developed for the treatment of multiple myeloma as combination therapy in patients who have received at least one prior therapy, now making it […]

May 13, 2016 - 3 minutesmins - By Dani Bancroft

oxstem regenerative medicine stem cell leukemia

News and Trends 12 May 2016

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

OxStem’s strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. A spin-out of Oxford University, OxStem is developing cell programming therapies that could treat a range of usually age-related conditions – dementia, heart failure, macular degeneration, […]

May 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 11 May 2016

German mRNA specialist moves into Animal Health in collaboration with Bayer

BioNTech is joining its mRNA technology with Bayer’s expertise in veterinary applications in a new collaboration – to develop first-in-class vaccines for animals. Based in Mainz (Germany), BioNTech is the largest private Biotech in Europe. Along with its CAR-T and TCR programmes, BioNTech is developing mRNA therapies – a promising field in medicine. These include immunotherapies for […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Biotech of the Week: High-quality genetic testing with Asper Biotech in Estonia

RNA therapy starts first-of-a-kind trial to treat Liver Cancer

First All-Cancer mRNA Vaccine that Works Published in Nature

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

It’s Blood Cancer Day, how is Biotech fixing it?

Qiagen partners up for Novel Diagnostic against Breast Cancer

Biotech of the Week: Immunicum, Immuno-oncology made in Sweden

FDA approves First ever antibody to target Cancer PD-L1

‘Ideal’ German Antibodies have promising data for Gastro Cancer

First and only antibody for Multiple Myeloma approved in EU

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

German mRNA specialist moves into Animal Health in collaboration with Bayer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!